In the 2 patients (S-28 and S-26) who showed a wildtype ESR1 according to biopsies but a mutated gene in cfDNAs, the differences were related to the heterogeneity of the tumor sample, or the evolution of the neoplasm over time. This evidence concerns the gene ESR1 and neoplasm.